アブストラクト
| Title | [透析患者に臨床でよく使用する薬の使い方] 骨粗鬆症 |
|---|---|
| Subtitle | 特集 合併症管理に強くなる! 透析患者の薬の使い方 |
| Authors | 山田真介, 稲葉雅章 |
| Authors (kana) | |
| Organization | 大阪市立大学大学院医学研究科代謝内分泌病態内科学 |
| Journal | 月刊薬事 |
| Volume | 62 |
| Number | 16 |
| Page | 3120-3124 |
| Year/Month | 2020 / 12 |
| Article | 報告 |
| Publisher | じほう |
| Abstract | [Points] ●慢性腎臓病(CKD)では早期より骨折リスクが上昇する. ●CKD合併骨粗鬆症では, 「カルシウム, リン, PTHの検査値異常」, 「骨代謝異常」, 「血管および軟部組織の石灰化」の3つの柱(CKD-MBDの概念)を包括的に管理する必要がある. ●現在のところ, CKD合併骨粗鬆症に対する明白な安全性と有効性を示しうる骨粗鬆症治療薬は存在しない. ●CKD合併骨粗鬆症治療を確立するための, さらなる治療経験の蓄積が必要である. |
| Practice | 薬学 |
| Keywords |
- 全文ダウンロード： 従量制、基本料金制の方共に803円(税込) です。
参考文献
- 1) Nickolas TL, et al : Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol, 17 : 3223-3232, 2006
- 2) Coco M, et al : Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis, 36 : 1115-1121, 2000
- 3) Malluche HH, et al : The importance of bone health in end-stage renal disease : out of the frying pan, into the fire? Nephrol Dial Transplant, 19(Suppl.1) : i9-i13, 2004
- 4) Kurajoh M, et al : Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in pre dialysis CRF patients : modulation by serum 25-OH-D. Osteoporos Int, 19 : 709-716, 2008
- 5) Ensrud KE, et al : Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med, 167 : 133-139, 2007
残りの18件を表示する
- 6) 日本透析医学会 : 慢性腎臓病に伴う骨・ミネラル代謝異常の診療ガイドライン. 日本透析医学会雑誌, 45 : 301-356, 2012
- 7) Jamal SA, et al : Alendronate treatment in women with normal to severe ly impaired renal function : an analysis of the fracture intervention trial. J Bone Miner Res, 22 : 503-508, 2007
- 8) Miller PD, et al : safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method : a pooled analysis of nine clinical trials. J Bone Miner Res, 20 : 2105-2115, 2005
- 9) Toussaint ND, et al : Effect of alendronate on vascular calcification in CKD stages 3 and 4 : a pilot randomized controlled trial. Am J Kidney Dis, 56 : 57-68, 2010
- 10) Ishani A, et al : The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol, 19 : 1430-1438, 2008
- 11) Adami S, et al : The efficacy and safety of bazedoxifene in postmenopausal women by baseline kidney function status. Climacteric, 17 : 273-284, 2014
- 12) Imai E, et al : Slower decline of glomerular filtration rate in the Japanese general population : a longitudinal 10-year follow-up study. Hypertens Res, 31 : 433-441, 2008
- 13) Mical LM, et al : Raloxifene, a selective estrogen receptor modulator, is renoprotective : a post-hoc analysis. Kidney Int, 79 : 241-249, 2011
- 14) Daniel C, et al : Treatment of hemodialysis-associated adynamic bone disease with teriparatide(PTH1-34) : a pilot study. Kidney Boold Press Res, 33 : 221-226, 2010
- 15) Efstathios M, et al : Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients : a pilot study. Am J Nephrol, 36 : 238-244, 2012
- 16) Geoffrey AB, et al : A single-dose study of denosumab in patients with various degrees of renal impairment. J Bone Miner Res, 27 : 1471-1479, 2012
- 17) Sophie AJ, et al : Effect of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res, 26 : 1829-1835, 2011
- 18) Hiramatsu R, et al : Denosumab for low bone mass in hemodialysis patients : a noncontrolled trial. Am J Kidney Dis, 66 : 175-177, 2015
- 19) Chen CL, et al : Effects of denosumab and calcitriol on severe secondary hyperparathyroidism in dialysis patients with low bone mass. J Clin Endocrinol Metab, 100 : 2784-2792, 2015
- 20) Carrilo-Lopez N, et al : Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int, 90 : 77-89, 2016
- 21) Kobayashi I, et al : Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients. Life Sci, 90 : 212-218, 2012
- 22) Kohno K, et al : Association of reduction in bone mineral density with mortality in male hemodialysis patients. Calcif Tissue Int, 84 : 180-185, 2009
- 23) Maeno Y, et al : Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients : a prospective observational study. Calcif Tissue Int, 85 : 310-316, 2009
